Delayed onset of experimental autoimmune encephalomyelitis in olig1 deficient mice

PLoS ONE

Volumn 5, Issue 9, 2010, Pages

  Guo, Xiaoli ^a   Harada, Chikako ^a   Namekata, Kazuhiko ^a   Mitamura, Yoshinori ^b   Yoshida, Hiroshi ^c   Matsumoto, Yoh ^a   Harada, Takayuki ^a,c  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; HELIX LOOP HELIX PROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; DEMYELINATION; DISEASE SEVERITY; ELECTRORETINOGRAM; FEMALE; INCIDENCE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVE FIBER DEGENERATION; NONHUMAN; OPTIC NERVE; OPTIC NEURITIS; PROTEIN EXPRESSION; SPINAL CORD; VISUAL IMPAIRMENT;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; MYELIN-ASSOCIATED GLYCOPROTEIN; TIME FACTORS;

ANIMALIA; MUS;

EID: 77958574391     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013083     Document Type: Article

References (29)

1. Magnus T, Rao MS (2005) Neural stem cells in inflammatory CNS diseases: mechanisms and therapy. J Cell Mol Med 9: 303-319.
2. Prineas JW, McDonald WI (1997) Demyelinating diseases. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology. Arnold, London, pp 813-896.
3. Raine CS (1997) Demyelinating diseases. In: Davis RL, Robertson DM, eds. Textbook of Neuropathology. Baltimore: Williams & Wilkins. pp 243-287.
4. Wolswijk G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18: 601-609.
5. Chang A, Tourtellotte WW, Rudick R, Trapp BD (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346: 165-173.
6. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, et al. (2002) Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8: 1115-1121.
7. Mi S, Hu B, Hahm K, Luo Y, Kam Hui ES, et al. (2007) LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 13: 1228-1233.
8. Zhang Y, Argaw AT, Gurfein BT, Zameer A, Snyder BJ, et al. (2009) Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc Natl Acad Sci USA 106: 19162-19167.
9. Jarius S, Paul F, Franciotta D, Waters P, Zipp F, et al. (2008) Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4: 202-214.
10. Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, et al. (2008) NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70: 2197-2200.
11. Zhou Q, Anderson DJ (2002) The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 109: 61-73.
12. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, et al. (2002) Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 109: 75-86.
13. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, et al. (2004) bHLH Transcription Factor Olig1 Is Required to Repair Demyelinated Lesions in the CNS. Science 306: 2111-2115.
14. Xin M, Yue T, Ma Z, Wu F, Gow A, et al. (2005) Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J Neurosci 25: 1354-1365.
15. Guo X, Nakamura K, Kohyama K, Harada C, Behanna HA, et al. (2007) Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis. Neurosci Res 59: 457-466.
16. Guo X, Harada C, Namekata K, Kikushima K, Mitamura Y, et al. (2009) Effect of geranylgeranylacetone on optic neuritis in experimental autoimmune encephalomyelitis. Neurosci Lett 462: 281-285.
17. Harada T, Harada C, Nakamura K, Quah HM, Okumura A, et al. (2007) The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest 117: 1763-1770.
18. Chen Y, Wu H, Wang S, Koito H, Li J, et al. (2009) The oligodendrocytespecific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nat Neurosci 12: 1398-1406.
19. Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, et al. (2009) Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med 15: 626-632.
20. Delarasse C, Daubas P, Mars L, Vizler C, Litzenburger T, et al. (2003) Myelin/ oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice. J Clin Invest 112: 544-553.
21. Prinz M, Garbe F, Schmidt H, Mildner A, Gutcher I, et al. (2006) Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest 116: 456-464.
22. Körner H, Riminton DS, Strickland DH, Lemckert FA, Pollard JD, et al. (1997) Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J Exp Med 186: 1585-1590.
23. Hickman SJ, Dalton CM, Miller DH, Plant GT (2002) Management of acute optic neuritis. Lancet 60: 1953-1962.
24. Liu Y, Rao MS (2004) Olig genes are expressed in a heterogeneous population of precursor cells in the developing spinal cord. Glia 45: 67-74.
25. Burton A (2005) Olig1 needed for remyelination. Lancet Neurol 4: 80.
26. Goris A, Yeo TW, Maranian M, Walton A, Ban M, et al. (2006) Novel Olig1- coding variants and susceptibility to multiple sclerosis. J Neurol Neurosurg Psychiatry 77: 1296-1297.
27. Harada T, Harada C, Kohsaka S, Wada E, Yoshida K, et al. (2002) Microglia-Müller glia cell interactions control neurotrophic factor production during lightinduced retinal degeneration. J Neurosci 22: 9228-9236.
28. +-ATPase via actin depolymerization. Mol Cell Biol 28: 3273-3280.
29. Namekata K, Harada C, Taya C, Guo X, Kimura H, et al. (2010) Dock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex. Proc Natl Acad Sci USA 107: 7586-7591.